Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 583.51-91.805.4623.93404.51

What is the latest EBIT Growth ratio of BALAXI PHARMACEUTICALS ?

The latest EBIT Growth ratio of BALAXI PHARMACEUTICALS is 583.51 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025583.51
Mar2024-91.80
Mar20235.46
Mar202223.93
Mar2021404.51

How is EBIT Growth of BALAXI PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 583.51
Positive
Mar2024 -91.8
Negative
Mar2023 5.46
-77.18
Mar2022 23.93
-94.08
Mar2021 404.51 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹146.0 Cr -2.3% -17.7% -64.4% Stock Analytics
ADANI ENTERPRISES ₹286,329.0 Cr -2.9% -1.5% -5.1% Stock Analytics
REDINGTON ₹21,944.4 Cr 1.6% 1.9% 45.8% Stock Analytics
MMTC ₹9,894.0 Cr -2% 22.9% -2.4% Stock Analytics
LLOYDS ENTERPRISES ₹9,756.2 Cr 2% 11.8% 34.4% Stock Analytics
HONASA CONSUMER ₹9,593.5 Cr 0.7% 13.1% 22.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2.3%

-17.7%

-64.4%

SENSEX

-1.2%

-1.1%

6.3%


You may also like the below Video Courses